Literature DB >> 20339294

Impact of lower urinary tract symptoms on discomfort in men aged between 50 and 80 years.

Grégoire Robert1, Aurélien Descazeaud, Rahmene Azzouzi, Christian Saussine, Olivier Haillot, Olivier Dumonceau, Charles Ballereau, Marc Fourmarier, Marian Devonec, Bertrand Lukacs, Nicolas Barry Delongchamps, Francois Desgrandchamps, Alexandre de la Taille.   

Abstract

BACKGROUND/AIMS: There are only a few surveys on the prevalence of lower urinary tract symptoms (LUTS) among the general population. The aim of this survey was to assess the prevalence of LUTS and their impact on discomfort in men.
METHODS: A questionnaire was mailed to 3,877 men aged 50-80 years, which included questions on their medical history, demographic and sociological status, and also the International Prostate Symptom Score (IPSS) with additional questions on discomfort related to urinary symptoms.
RESULTS: The response rate was 81.5%. Prevalence of mild and severe IPSS was 89.2%. Specific bother for each urinary symptom depended on symptom frequency: urgency, frequency, weak stream, nocturia, incomplete emptying, intermittency and straining 1 time out of 5 were responsible for discomfort in respectively 4.9, 6.1, 7.1, 7.5, 8.7 and 9.9%; the same symptoms more than half of the time were responsible for discomfort in respectively 32.8, 38, 45.3, 45.6, 53.2 and 58.7%. Urgency was much more deeply implicated in discomfort than frequency of nocturia.
CONCLUSIONS: Urinary symptoms in men are very common. Nocturia is the most frequent but has a low impact on discomfort. Urgency has a higher impact on discomfort and should therefore be considered in treatment decision-making. Copyright (c) 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20339294     DOI: 10.1159/000304509

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  7 in total

1.  The prevalence of lower urinary tract symptoms in a Chinese population, and the correlation with uroflowmetry and disease perception.

Authors:  Chi-Hang Yee; Joseph K M Li; Hon-Chung Lam; Eddie S Y Chan; Simon See-Ming Hou; Chi-Fai Ng
Journal:  Int Urol Nephrol       Date:  2013-10-18       Impact factor: 2.370

2.  Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia.

Authors:  Richard-Olivier Fourcade; François Lacoin; Morgan Rouprêt; Alain Slama; Camille Le Fur; Emilie Michel; Axel Sitbon; François-Emery Cotté
Journal:  World J Urol       Date:  2011-09-03       Impact factor: 4.226

3.  What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women.

Authors:  Arnav Agarwal; Leyla N Eryuzlu; Rufus Cartwright; Kristian Thorlund; Teuvo L J Tammela; Gordon H Guyatt; Anssi Auvinen; Kari A O Tikkinen
Journal:  Eur Urol       Date:  2014-01-24       Impact factor: 20.096

4.  Distress Due to Urinary Problems and Psychosocial Correlates among Retired Men in Hong Kong.

Authors:  Marcus Yu Lung Chiu; Ho Ting Wong; Xue Yang
Journal:  Int J Environ Res Public Health       Date:  2020-04-07       Impact factor: 3.390

5.  Clinical Significance of the Resistive Index of Prostatic Blood Flow According to Prostate Size in Benign Prostatic Hyperplasia.

Authors:  Se Yun Kwon; Jung Woo Ryu; Dai Hai Choi; Kyung Seop Lee
Journal:  Int Neurourol J       Date:  2016-03-14       Impact factor: 2.835

6.  Is It Worth Treating Non-Bothering Nocturia? Results of a Multicenter Prospective Observational Study.

Authors:  Kwangsung Park; Hyoung Keun Park; Sae Woong Kim; Dae Yul Yang; Jong Kwan Park; Hyun Jun Park; Ki Hak Moon; Du Geon Moon; Kweon Sik Min; Hwancheol Son; Sung Won Lee; Jae Seog Hyun; Woo Suk Choi; Sang Kuk Yang
Journal:  World J Mens Health       Date:  2018-05-17       Impact factor: 5.400

Review 7.  WS PRO 160 I 120 mg (a combination of sabal and urtica extract) in patients with LUTS related to BPH.

Authors:  Ruth Kirschner-Hermanns; Petra Funk; Nadine Leistner
Journal:  Ther Adv Urol       Date:  2019-10-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.